Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Genprex, Inc.GNPX · Entity 8441 | Director · President, CEO and CFO | February 27, 2026 | February 27, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Genprex, Inc.
Report date February 27, 2026 · Filed February 27, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 36,331 |
Reported balance
After 2026-02-27 transaction · row 1
1 source rowRow 1 · 2026-02-27 · Tax withholding · Disposed 9,330 · Balance 36,331 F1: Represents shares withheld on February 27, 2026 to satisfy tax withholding obligations in connection with the vesting of Restricted Stock Units ("RSUs") previously granted under the Genprex, Inc. 2018 Equity Incentive Plan (as amended and restated effective June 30, 2025). |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares withheld on February 27, 2026 to satisfy tax withholding obligations in connection with the vesting of Restricted Stock Units ("RSUs") previously granted under the Genprex, Inc. 2018 Equity Incentive Plan (as amended and restated effective June 30, 2025).
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 27, 2026 Filed Feb 27, 2026 18:33 UTC | Genprex, Inc. GNPX · Entity 8441 | Tax withholdingCommon Stock | 9,330 | $2.00 | $18,660.00 |
DisclosureSEC source: 0001437749-26-006153 · rdgdoc.xml · nonDerivative · entry 1 Confer Ryan M. · CIK 0001735541 · Director · President, CEO and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,331 F1 · shares: Represents shares withheld on February 27, 2026 to satisfy tax withholding obligations in connection with the vesting of Restricted Stock Units ("RSUs") previously granted under the Genprex, Inc. 2018 Equity Incentive Plan (as amended and restated effective June 30, 2025). Read SEC document |
| December 22, 2025 Filed Dec 23, 2025 17:34 UTC | Genprex, Inc. GNPX · Entity 8441 | GrantCommon Stock | 45,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-038734 · rdgdoc.xml · nonDerivative · entry 1 Confer Ryan M. · CIK 0001735541 · Director · President, CEO and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,661 F1 · shares: This award of Restricted Stock Units ("RSUs") is granted under the Genprex, Inc. (the "Company") 2018 Equity Incentive Plan (as amended and restated effective June 30, 2025, the "EIP") and vests in installments of 50% on February 27, 2026 and the remaining 50% on February 27, 2027, provided that the recipient continues to serve as a Service Provider (as defined in the Company's EIP) through the applicable vesting dates. Vested RSUs will be paid in shares of the Company's common stock, $0.001 par value, on a one-to-one basis. F2 · balance_after: This total represents the number of shares of Common Stock beneficially owned following this reported transaction and the 1-for-50 reverse stock split of the Company's Common Stock effected as of October 21, 2025. Read SEC document |
| June 30, 2025 Filed Jul 1, 2025 17:51 UTC | Genprex, Inc. GNPX · Entity 8441 | Tax withholdingCommon Stock | 5,775 | $0.23 | $1,316.12 |
DisclosureSEC source: 0001437749-25-021817 · rdgdoc.xml · nonDerivative · entry 1 Confer Ryan M. · CIK 0001735541 · Director · President, CEO and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,968 F1 · shares: Represents shares withheld on June 30, 2025 to satisfy tax withholding obligations in connection with the vesting of Restricted Stock Units ("RSUs") previously granted under the Genprex, Inc. (the "Company") 2018 Equity Incentive Plan. Read SEC document |
| February 18, 2025 Filed Feb 19, 2025 20:00 UTC | Genprex, Inc. GNPX · Entity 8441 | Tax withholdingCommon Stock | 395 | $0.41 | $161.95 |
DisclosureSEC source: 0001437749-25-004464 · rdgdoc.xml · nonDerivative · entry 1 Confer Ryan M. · CIK 0001735541 · Director · President, CEO and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,743 F1 · shares: Represents shares withheld on February 18, 2025 to satisfy tax withholding obligations in connection with the vesting of Restricted Stock Units ("RSUs") previously granted under the Genprex, Inc. (the "Company") 2018 Equity Incentive Plan. Read SEC document |
| December 05, 2024 Filed Dec 6, 2024 17:50 UTC | Genprex, Inc. GNPX · Entity 8441 | GrantCommon Stock | 29,375 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-036880 · rdgdoc.xml · nonDerivative · entry 1 Confer Ryan M. · CIK 0001735541 · Director · President, CEO and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,138 F1 · shares: This award of Restricted Stock Units ("RSUs") is granted under the Genprex, Inc. (the "Company") 2018 Equity Incentive Plan and vests 100% as of June 30, 2025, provided that the recipient continues to serve as a Service Provider (as defined in the Company's 2018 Equity Incentive Plan) through the applicable vesting date. Vested RSUs will be paid in shares of the Company's common stock, $0.001 par value, on a one-to-one basis. Read SEC document |
| February 18, 2024 Filed Feb 21, 2024 16:28 UTC | Genprex, Inc. GNPX · Entity 8441 | Tax withholdingCommon Stock | 1,126 | $4.40 | $4,954.40 |
DisclosureSEC source: 0001437749-24-005055 · rdgdoc.xml · nonDerivative · entry 1 Confer Ryan M. · CIK 0001735541 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,763 F1 · shares: Represents shares withheld on February 18, 2024 to satisfy tax withholding obligations in connection with the vesting of Restricted Stock Units ("RSUs") previously granted under the Genprex, Inc. (the "Company") 2018 Equity Incentive Plan. F2 · balance_after: This total represents the number of shares of Common Stock beneficially owned following this reported transaction and the 1-for-40 reverse stock split of the Company's Common Stock effected as of February 2, 2024. Read SEC document |
| February 18, 2023 Filed Feb 22, 2023 18:25 UTC | Genprex, Inc. GNPX · Entity 8441 | GrantCommon Stock | 245,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-004237 · rdgdoc.xml · nonDerivative · entry 1 Confer Ryan M. · CIK 0001735541 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 435,499 F1 · shares: This award of Restricted Stock Units ("RSUs") is granted under the Genprex, Inc. (the "Company") 2018 Equity Incentive Plan and vests in installments of 50% on the first anniversary of the date of grant and the remaining 50% on the second anniversary of the date of grant. Vested RSUs will be paid in shares of the Company's common stock, $0.001 par value, on a one-to-one basis. Read SEC document |
| July 28, 2022 Filed Aug 1, 2022 17:30 UTC | Genprex, Inc. GNPX · Entity 8441 | Exercise / conversionStock Option (right to buy) · Derivative | 116,973 | $0.00 Strike: $0.02 | $0.00 |
DisclosureSEC source: 0001437749-22-018277 · rdgdoc.xml · derivative · entry 2 Confer Ryan M. · CIK 0001735541 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 116,973 shares Expires 2022-07-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 28, 2022 Filed Aug 1, 2022 17:30 UTC | Genprex, Inc. GNPX · Entity 8441 | Exercise / conversionCommon Stock | 116,973 | $0.02 | $1,754.60 |
DisclosureSEC source: 0001437749-22-018277 · rdgdoc.xml · nonDerivative · entry 1 Confer Ryan M. · CIK 0001735541 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 190,499 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 04, 2022 Filed Feb 8, 2022 16:38 UTC | Genprex, Inc. GNPX · Entity 8441 | GrantStock Option (right to buy) · Derivative | 341,750 | $0.00 Strike: $2.20 | $0.00 |
DisclosureSEC source: 0001437749-22-002748 · rdgdoc.xml · derivative · entry 1 Confer Ryan M. · CIK 0001735541 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 341,750 Underlying: Common Stock · 341,750 shares Expires 2032-02-04 F1 · derivative.exercise_date: The option (the "Option") was granted under the Genprex, Inc. (the "Company") 2018 Equity Incentive Plan (the "Plan"). The Option shall vest and become exercisable as to one third (1/3) of the total number of shares (the "Shares") of the Company's common stock, $.001 par value subject to the Option on February 4, 2023 (the "Vesting Commencement Date") and thereafter shall vest and become exercisable as to an additional 1/24 of the remaining Shares subject to the Option on each monthly anniversary of the Vesting Commencement Date until fully vested and exercisable, in each case provided that the Optionee continues to serve as a Service Provider (as defined in the Plan) through the applicable vesting date. Read SEC document |
| March 19, 2021 Filed Mar 23, 2021 16:48 UTC | Genprex, Inc. GNPX · Entity 8441 | GrantStock Option (right to buy) · Derivative | 235,000 | $0.00 Strike: $5.08 | $0.00 |
DisclosureSEC source: 0001437749-21-006915 · rdgdoc.xml · derivative · entry 1 Confer Ryan M. · CIK 0001735541 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 235,000 Underlying: Common Stock · 235,000 shares Expires 2031-03-19 F1 · derivative.exercise_date: One third (1/3) of the Shares subject to the Option shall vest on each annual anniversary of March 19, 2021 so that one hundred percent (100%) of the shares subject to the Option are vested on the third anniversary of March 19, 2021 provided that the optionee continues to serve as a Service Provider (as defined in Genprex, Inc. 2018 Equity Incentive Plan) through the applicable vesting date. Read SEC document |
| August 21, 2020 Filed Aug 25, 2020 17:54 UTC | Genprex, Inc. GNPX · Entity 8441 | GrantStock Option (right to buy) · Derivative | 270,000 | $0.00 Strike: $3.80 | $0.00 |
DisclosureSEC source: 0001437749-20-018691 · rdgdoc.xml · derivative · entry 1 Confer Ryan M. · CIK 0001735541 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 270,000 Underlying: Common Stock · 270,000 shares Expires 2030-08-20 F1 · derivative.exercise_date: One thirty-sixth (1/36) of the Shares subject to the Option shall vest on each monthly anniversary of August 21, 2020 so that one hundred percent (100%) of the shares subject to the Option are vested on the third anniversary of August 21, 2020, provided that the optionee continues to serve as a Service Provider (as defined in Genprex, Inc. 2018 Equity Incentive Plan) through the applicable vesting date. Read SEC document |
| January 25, 2019 Filed Jan 29, 2019 14:42 UTC | Genprex, Inc. GNPX · Entity 8441 | GrantStock Option (Right to Buy) · Derivative | 230,769 | $0.00 Strike: $1.62 | $0.00 |
DisclosureSEC source: 0001209191-19-005723 · doc4.xml · derivative · entry 1 Confer Ryan M. · CIK 0001735541 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 230,769 Underlying: Common Stock · 230,769 shares Expires 2029-01-25 F1 · derivative.exercise_date: One thirty-sixth (1/36) of the Shares subject to the Option shall vest on each monthly anniversary of January 25, 2019 so that one hundred percent (100%) of the shares subject to the Option are vested on the third anniversary of January 25, 2019. Read SEC document |
| May 23, 2018 Filed May 25, 2018 17:41 UTC | Genprex, Inc. GNPX · Entity 8441 | GrantStock option (right to buy) · Derivative | 327,236 | $0.00 Strike: $9.80 | $0.00 |
DisclosureSEC source: 0001185185-18-001004 · form4-confer052518.xml · derivative · entry 1 Confer Ryan M. · CIK 0001735541 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 327,236 Underlying: Common Stock · 327,236 shares Expires 2028-05-23 F1 · derivative.exercise_date: 1/3 of the shares vest on 5/23/2018; the remaining 2/3 of the shares vest in equal quarterly installments over the following 3 years. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.